2024-512296-13-00招募中1 期
A First-In-Human, Phase I/IIa Trial of the novel T cell Immunotherapy pTTL in Patients with Advanced Colorectal Cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 16
- 试验地点
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Chief Technical Officer
Scientific
NEOGAP Therapeutics AB
研究点 (3)
Loading locations...
相似试验
撤回
2 期
Cancer Molecular Screening and Therapeutics (MoST) Program Substudy Addendum 13 substudy 31: EntrectinibCancer - Lung - Non small cellCancer - Any cancerCancerACTRN12621000284864The University of Sydney16
已完成
1 期
Mesenchymal Stem Cells Transplantation in newly diagnosed Type-1 Diabetes PatientsDiabetes.Insulin-dependent diabetes mellitusIRCT2016070428786N1Royan Institute20
尚未招募
不适用
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
尚未招募
不适用
A phase 2 trial to assess efficacy and safety of Enhertu in HER2-mutant advanced lung cancer patients with asymptomatic brain metastasesNeoplasmsKCT0009147Yonsei University Health System, Severance Hospital27
已完成
不适用
Tryton I, A first in man clinical evaluation of the TRYTON * Sidebranch stent.10011082bifurcationNL-OMON30192Tryton Medical, Inc.,10